Ann: First KOL appointed to undertake FELIX assessment, page-12

these guys are at clinical trial 3 atm. they have a viable product that is been given to leading researchers and practitioners for testing. personally, I like the way the management team is thinking. they've selected individuals with high influence for testing so that the successful results will be able to spread quicker and wider. intelligent management team with a patent on a successful product. I think the company should be valued at least at .10$. after they receive FDA approval it seems they're product will sky rocket. at least $.50 at that point.

my only question is if anyone knows what their business model is? are they selling the main machine then a recurring fee for the cartridge?